This brand name is authorized in Netherlands.
The drug INHIBIN contains one active pharmaceutical ingredient (API):
1
|
UNII
31J3Q51T6L - HYDROQUININE
|
|
Hydroquinidine is a d-rotatory alkaloid derived from cinchiona bark. Hydroquinidine is a pharmaceutical agent that acts as a class I antiarrhythmic agent (Ia) in the heart. Hydroquinidine causes increased action potential duration, as well as a prolonged QT interval. Like all other class I antiarrhythmic agents, hydroquinidine primarily works by blocking the fast inward sodium current (INa). Hydroquinidine is also used for the treatment of Malaria. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| M09AA01 | Hydroquinine | M Musculo-skeletal system → M09 Other drugs for disorders of the musculo-skeletal system → M09A Other drugs for disorders of the musculo-skeletal system → M09AA Quinine and derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NL | Z-Index G-Standaard, PRK | 32751 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.